On September 25, 2025, Anebulo announced the first subjects dosed in a Phase 1 single ascending dose ("SAD") study of an intravenous (IV) formulation of its lead drug candidate selonabant. Selonabant ...

President, Ratu Naiqama Lalabalavu, visited the Sri Sathya Sai Sanjeevani Hospital in Muddenahalli, India, a medical facility providing free, high-quality healthcare for children and families in need.